FACTORS INFLUENCING COMPARATIVE BIOAVAILABILITY OF SPIRONOLACTONE TABLETS

被引：26

作者：

CLARKE, JM ^{[1
]}

RAMSAY, LE ^{[1
]}

SHELTON, JR ^{[1
]}

TIDD, MJ ^{[1
]}

MURRAY, S ^{[1
]}

PALMER, RF ^{[1
]}

机构：

[1] GD SEARLE & CO LTD,DIV SCI AFFAIRS,HIGH WYCOMBE HP12 4HL,BUCKINGHAMSHIRE,ENGLAND

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1977年 / 66卷 / 10期

关键词：

D O I：

10.1002/jps.2600661020

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1429 / 1432

页数：4

共 20 条

[1]

BAUER G, 1962, ARZNEIMITTEL-FORSCH, V12, P487

[2]

CHODOS DJ, 1973, BASICS BIOAVAILABILI

[3]

COCHRAN WG, 1957, EXPT DESIGNS, P507

[4] ALDOSTERONE BLOCKING EFFECTS OF SPIROLACTONES [J].

DRILL, VA .

JAPANESE JOURNAL OF PHARMACOLOGY, 1962, 11 (02) :77-&

[5]

GANTT CL, 1963, METABOLISM, V12, P1007

[6]

GANTT CL, 1961, LANCET, V1, P486

[7]

GANTT CL, 1962, LANCET, V1, P1130

[8]

GOCHMAN N, 1962, J PHARMACOL EXP THER, V135, P312

[9] COMPARISON OF SPIRONOLACTONE TABLET DOSAGE FORMS IN HEALTHY HUMANS [J].

HOFMANN, LM ;

DUTT, JE ;

DEYSACH, LG ;

LONCIN, H ;

TAO, L .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (08) :1248-1253

[10] EFFECT OF PARTICLE-SIZE ON BIOAVAILABILITY OF DIGOXIN [J].

JOUNELA, AJ ;

PENTIKAINEN, PJ ;

SOTHMANN, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (05) :365-370

← 1 2 →